Haemonetics buys Infonale

Haemonetics Corp. said today it has acquired Infonale Inc. for $1.3 million, plus contingent consideration based upon future operating performance.

Haemonetics of Braintree is a provider of blood management solutions, and Infonale of Pennsylvania is a developer of software for optimizing hospital blood use and management.

At a recent shareholders meeting in May, Haemonetics said it outlined a vision to bring its blood collection and hospital customers a suite of blood management solutions that can reduce costs and improve clinical outcomes; Infonale's proprietary software, clinical data base, and consulting services support that vision, Haemonetics said.

Haemonetics is committed to "a total customer value proposition," and Tom Lawlor, president of the company's patient division, noted in a statement, "In the past year, we've introduced four new products that expand Haemonetics' reach in the surgical suite."
(By Chris Reidy, Globe staff)